231 related articles for article (PubMed ID: 9328969)
21. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
22. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
Maas R; Hofstra JM; Wetzels JF
Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppression for membranous nephropathy.
Lancet; 1989 Jan; 1(8631):211-2. PubMed ID: 2563109
[No Abstract] [Full Text] [Related]
24. Idiopathic membranous nephropathy in the elderly.
Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
[TBL] [Abstract][Full Text] [Related]
25. Therapy of membranous nephropathy with severe azotemia.
Prabhakar S; Kahn T
Clin Nephrol; 1996 Jun; 45(6):419. PubMed ID: 8793240
[No Abstract] [Full Text] [Related]
26. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency.
Branten AJ; Reichert LJ; Koene RA; Wetzels JF
QJM; 1998 May; 91(5):359-66. PubMed ID: 9709470
[TBL] [Abstract][Full Text] [Related]
27. Chlorambucil-induced acute hepatic failure in a patient with membranous nephropathy.
Patel SP; Nast CC; Adler SG
Am J Kidney Dis; 2000 Aug; 36(2):401-4. PubMed ID: 10922320
[TBL] [Abstract][Full Text] [Related]
28. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
[TBL] [Abstract][Full Text] [Related]
29. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
30. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
31. [Immunosuppressive therapy for idiopathic membranous glomerulopathy].
Branten AJ; Wetzels JF
Ned Tijdschr Geneeskd; 1998 Apr; 142(14):767-72. PubMed ID: 9646608
[TBL] [Abstract][Full Text] [Related]
32. [Membranous nephropathy and crescentic glomerulonephritis].
Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
[TBL] [Abstract][Full Text] [Related]
33. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
34. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
35. Idiopathic membranous nephropathy in two siblings.
Maccario M; Segagni S; Efficace E; Piazza V; Poggio F; Villa G; Picardi L; Bovio G; Galli F; Nai M
Nephrol Dial Transplant; 1995; 10(1):108-10. PubMed ID: 7724003
[No Abstract] [Full Text] [Related]
36. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
37. [Membranous nephropathy].
Passos EM; Legallicier B; Godin M
Rev Prat; 2003 Nov; 53(18):2033-8. PubMed ID: 15008218
[TBL] [Abstract][Full Text] [Related]
38. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with non-steroidal anti-inflammatory drugs.
Grcevska L; Polenaković M; Ferluga D; Vizjak A; Stavrić G
Clin Nephrol; 1993 May; 39(5):250-3. PubMed ID: 8513600
[TBL] [Abstract][Full Text] [Related]
39. Development of bronchial adenocarcinoma 11 years after the onset of membranous nephropathy associated with chlorambucil therapy.
Polenaković M; Grcevska L
Nephron; 1995; 69(3):335-6. PubMed ID: 7753270
[No Abstract] [Full Text] [Related]
40. [Treatment of idiopathic membranous glomerulonephritis with steroids and immunosuppressors].
Vigil A; Oliet A; Gallar P; Ortega O; Rodríguez Villarreal I
Nefrologia; 2000; 20(3):291-4. PubMed ID: 10917007
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
